PubRank

A Novel Case of Penile Gangrene in a Patient Treated with Ibrutinib for Chronic Lymphocytic Leukemia.

PubWeight™: 0.75‹?›

🔗 View Article (PMID 27999696)

Published in Case Rep Oncol Med on November 23, 2016

Authors

William Paul Skelton Iv1, Neeka N Akhavan1, Zachary A Taylor1, Thu-Cuc Nguyen2, Hassan Hassan3, Tabitha N Townsend4, Prajwol Pathak5, Gaurav Trikha4, Nam H Dang4, Long H Dang4, Azka Ali1

Author Affiliations

1: Department of Internal Medicine, University of Florida, Gainesville, FL, USA.
2: Department of Internal Medicine, University of Central Florida, Orlando, FL, USA.
3: Cancer Specialists of North Florida, Saint Augustine, FL, USA.
4: Division of Hematology and Oncology, Department of Internal Medicine, University of Florida, Gainesville, FL, USA.
5: Division of Hematology and Oncology, Department of Medicine, University of Florida, Gainesville, FL, USA.

Articles cited by this ↗

Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci U S A (2002) 32.26

Targeting BTK with ibrutinib in relapsed chronic lymphocytic leukemia. N Engl J Med (2013) 16.33

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet (2010) 13.59

Chronic lymphocytic leukemia. N Engl J Med (2005) 9.99

Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765. Blood (2011) 5.98

Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia. N Engl J Med (2015) 5.69

Chlorambucil in indolent chronic lymphocytic leukemia. French Cooperative Group on Chronic Lymphocytic Leukemia. N Engl J Med (1998) 2.68

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell (2011) 2.62

Chemotherapeutic options in chronic lymphocytic leukemia: a meta-analysis of the randomized trials. CLL Trialists' Collaborative Group. J Natl Cancer Inst (1999) 2.13

Molecular pathogenesis of chronic lymphocytic leukemia. J Clin Invest (2012) 1.64

Understanding, recognizing, and managing toxicities of targeted anticancer therapies. CA Cancer J Clin (2013) 1.54

Chronic lymphocytic leukemia: 2015 Update on diagnosis, risk stratification, and treatment. Am J Hematol (2015) 1.48

Penile gangrene: a devastating and lethal entity. Saudi J Kidney Dis Transpl (2011) 0.91

Practical approach to management of chronic lymphocytic leukemia. Arch Med Sci (2015) 0.80

Articles by these authors ⇆

Synchronous Occurrence of Chronic Myeloid Leukemia and Mantle Cell Lymphoma. Case Rep Hematol (2017) 0.75

Low Grade Lymphoma Mimicking Metastatic Urothelial Carcinoma: When Do We Need Further Histologic Staging? Case Rep Oncol Med (2016) 0.75

Lung Adenocarcinoma Presenting as Worsening of Chronic Neck Pain-A Cautionary Tale. Clin Med Insights Case Rep (2017) 0.75